Equities

DIOD PAO

DIOD PAO

Actions
  • Price (RUB)16.60
  • Today's Change0.20 / 1.22%
  • Shares traded22.80k
  • 1 Year change+55.14%
  • Beta--
Data delayed at least 30 minutes, as of May 10 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Diod PAO (Zavod ekologicheskoy tekhniki i ekopitaniya Diod PAO) is a Russia-based company primarily engaged in the pharmaceutical sector. Its main activities comprise the development and production of medicines based on natural raw materials, dietary supplements, medical cosmetic products, as well as medical equipment. Its products portfolio consists of such dietary supplements as iodine, selenium and calcium based vitamins, among others; pharmaceutical products; medical cosmetic products; and such equipment as silver water purifier and light therapy apparatus, among others. In addition, it owns a medical center Mir ekologii, which provides healthcare services. The Company operates through several subsidiaries and affiliated companies.

  • Revenue in RUB (TTM)548.82m
  • Net income in RUB7.68m
  • Incorporated2002
  • Employees--
  • Location
    DIOD PAOul. Derbenevskayad.11A, stroyeniye 13, komnata 4MOSCOW 115114Russian FederationRUS
  • Phone+7 4 992357780
  • Fax+7 4 992353777
  • Websitehttp://www.diod.ru/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Enorama Pharma AB10.39m-375.08m1.37bn----6.73--131.54-2.16-2.160.04230.43090.03061.070.3212---110.45-64.94-277.27-94.45-267.0886.49-3,609.52-405.420.7249--0.023---37.9634.20-51.50------
Synairgen plc0.00-1.16bn1.37bn30.00--0.7392-----0.0496-0.04960.000.07930.00----0.00-41.40-54.75-48.86-60.72-------83,247.62----0.00------63.74--0.00--
Addex Therapeutics Ltd168.25m-1.08bn1.38bn23.00--8.02--8.22-0.1433-0.14330.02220.00920.2549--14.8271,612.17-163.36-69.05-312.84-84.19-----640.91-572.59---34.120.2311--13.99-24.4749.26---5.45--
Vivesto AB0.00-1.10bn1.39bn14.00--0.8242-----0.2414-0.24140.000.36760.00----0.00-44.66---48.73--------------0.00---100.00--64.80------
Abingdon Health PLC619.42m-259.06m1.41bn82.00--6.71--2.28-0.0184-0.01840.04390.01490.89787.674.7465,170.73-37.55-51.31-58.04-79.8557.3533.16-41.82-139.641.59--0.3572--42.68--83.77------
AlzeCure Pharma AB0.00-319.30m1.42bn11.00--8.41-----0.5685-0.56850.000.21220.00----0.00-92.80-52.78-115.25-57.01------------0.00------33.91------
Mithra Pharmaceuticals SA4.01bn-17.31bn1.44bn229.00------0.3599-2.51-2.510.6363-1.490.11020.44520.777---47.60-22.24-70.17-27.6945.3473.13-432.08-199.110.4339-3.072.01---40.06-7.05-191.01------
Ikonisys SA53.74m-239.02m1.47bn11.00--0.8063--27.36-0.2499-0.24990.0561.750.02461.146.2048,960.00-10.94---12.55--2.72---444.76--0.0818-36.790.1007--68.94---328.57------
Plant Advanced Technologies PAT SA233.40m-84.72m1.49bn56.00--2.02--6.36-0.7853-0.78532.156.700.13680.98692.8741,767.86-4.91-3.18-7.20-4.0422.8398.91-35.87-27.900.8691-16.730.4472--1.4823.7225.13--3.57--
Diod PAO548.82m7.68m1.50bn--195.381.3351.772.730.08390.08396.0012.370.39710.76961.84--0.60913.380.66743.7151.9856.531.538.294.22--0.0461---2.21-6.65-80.99-6.9017.47--
PMD Device Solutions AB244.20m-308.65m1.50bn1.00------6.15-16.69-16.696.34-4.790.9465--57.42---119.63------58.18---126.39--0.0505-3.00----------------
Provexis plc69.32m-57.56m1.51bn2.00--12.97--21.76-0.0002-0.00020.00030.00040.67173.042.95299,040.00-55.78-48.82-41.86-33.6846.7286.14-83.03-97.641.96--0.00---8.5110.58-71.79------
Kancera AB0.00-553.60m1.52bn3.00---------0.786-0.7860.00--------0.00---54.82---66.21-------7,249.06-------------23.64------
Incanthera PLC0.00-171.08m1.55bn8.00---------0.0192-0.01920.00-0.00860.00----0.00-373.20-101.74---132.88---------------------36.11------
Active Biotech AB publ0.00-390.75m1.64bn11.00--6.25-----0.172-0.1720.000.08480.00-------96.37-57.97-126.15-97.83-------1,454.61----0.1291------21.54------
Data as of May 10 2024. Currency figures normalised to DIOD PAO's reporting currency: Russian Ruble RUB
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.